Literature DB >> 23981442

Stress-response pathways are altered in the hippocampus of chronic alcoholics.

Jeanette N McClintick1, Xiaoling Xuei, Jay A Tischfield, Alison Goate, Tatiana Foroud, Leah Wetherill, Marissa A Ehringer, Howard J Edenberg.   

Abstract

The chronic high-level alcohol consumption seen in alcoholism leads to dramatic effects on the hippocampus, including decreased white matter, loss of oligodendrocytes and other glial cells, and inhibition of neurogenesis. Examining gene expression in post mortem hippocampal tissue from 20 alcoholics and 19 controls allowed us to detect differentially expressed genes that may play a role in the risk for alcoholism or whose expression is modified by chronic consumption of alcohol. We identified 639 named genes whose expression significantly differed between alcoholics and controls at a False Discovery Rate (FDR) ≤ 0.20; 52% of these genes differed by at least 1.2-fold. Differentially expressed genes included the glucocorticoid receptor and the related gene FK506 binding protein 5 (FKBP5), UDP glycosyltransferase 8 (UGT8), urea transporter (SLC14A1), zinc transporter (SLC39A10), Interleukin 1 receptor type 1 (IL1R1), thioredoxin interacting protein (TXNIP), and many metallothioneins. Pathways related to inflammation, hypoxia, and stress showed activation, and pathways that play roles in neurogenesis and myelination showed decreases. The cortisol pathway dysregulation and increased inflammation identified here are seen in other stress-related conditions such as depression and post-traumatic stress disorder and most likely play a role in addiction. Many of the detrimental effects on the hippocampus appear to be mediated through NF-κB signaling. Twenty-four of the differentially regulated genes were previously identified by genome-wide association studies of alcohol use disorders; this raises the potential interest of genes not normally associated with alcoholism, such as suppression of tumorigenicity 18 (ST18), BCL2-associated athanogene 3 (BAG3), and von Willebrand factor (VWF).
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcoholism; Cortisol; GWAS; Gene expression; Hippocampus; Inflammation; NF-κB; Stress

Mesh:

Substances:

Year:  2013        PMID: 23981442      PMCID: PMC3836826          DOI: 10.1016/j.alcohol.2013.07.002

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  93 in total

Review 1.  Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome.

Authors:  Antonio Armario
Journal:  Trends Pharmacol Sci       Date:  2010-05-25       Impact factor: 14.819

2.  Genome-wide association study of alcohol dependence implicates KIAA0040 on chromosome 1q.

Authors:  Lingjun Zuo; Joel Gelernter; Clarence K Zhang; Hongyu Zhao; Lingeng Lu; Henry R Kranzler; Robert T Malison; Chiang-Shan R Li; Fei Wang; Xiang-Yang Zhang; Hong-Wen Deng; John H Krystal; Fengyu Zhang; Xingguang Luo
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 3.  Stress, dysregulation of drug reward pathways, and the transition to drug dependence.

Authors:  George Koob; Mary Jeanne Kreek
Journal:  Am J Psychiatry       Date:  2007-08       Impact factor: 18.112

4.  The role of MT in neurological disorders.

Authors:  Michael Aschner; Adrian K West
Journal:  J Alzheimers Dis       Date:  2005-11       Impact factor: 4.472

Review 5.  Neuroimmune signaling: a key component of alcohol abuse.

Authors:  Jody Mayfield; Laura Ferguson; R Adron Harris
Journal:  Curr Opin Neurobiol       Date:  2013-02-22       Impact factor: 6.627

6.  Association of alcohol craving with alpha-synuclein (SNCA).

Authors:  Tatiana Foroud; Leah Flury Wetherill; Tiebing Liang; Danielle M Dick; Victor Hesselbrock; John Kramer; John Nurnberger; Marc Schuckit; Lucinda Carr; Bernice Porjesz; Xiaoling Xuei; Howard J Edenberg
Journal:  Alcohol Clin Exp Res       Date:  2007-04       Impact factor: 3.455

7.  Critical role for glucocorticoid receptors in stress- and ethanol-induced locomotor sensitization.

Authors:  A J Roberts; C N Lessov; T J Phillips
Journal:  J Pharmacol Exp Ther       Date:  1995-11       Impact factor: 4.030

Review 8.  Neurogenesis and Alzheimer's disease: at the crossroads.

Authors:  Orly Lazarov; Robert A Marr
Journal:  Exp Neurol       Date:  2009-08-19       Impact factor: 5.330

Review 9.  Gene-environment interactions resulting in risk alcohol drinking behaviour are mediated by CRF and CRF1.

Authors:  Toni-Kim Clarke; Gunter Schumann
Journal:  Pharmacol Biochem Behav       Date:  2009-05-03       Impact factor: 3.533

Review 10.  Mechanisms of neurodegeneration and regeneration in alcoholism.

Authors:  Fulton T Crews; Kim Nixon
Journal:  Alcohol Alcohol       Date:  2008-10-21       Impact factor: 2.826

View more
  46 in total

Review 1.  Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Authors:  Anne Q Fosnocht; Lisa A Briand
Journal:  Physiol Behav       Date:  2016-02-19

2.  Effects of chronic intermittent ethanol exposure and withdrawal on neuroblastoma cell transcriptome.

Authors:  Jeanette N McClintick; Kriti Thapa; Yunlong Liu; Xiaoling Xuei; Howard J Edenberg
Journal:  Alcohol       Date:  2020-01-07       Impact factor: 2.405

3.  Understanding the addiction cycle: a complex biology with distinct contributions of genotype vs. sex at each stage.

Authors:  C J Wilhelm; J G Hashimoto; M L Roberts; M K Sonmez; K M Wiren
Journal:  Neuroscience       Date:  2014-09-04       Impact factor: 3.590

4.  Chronic alcohol exposure differentially affects activation of female locus coeruleus neurons and the subcellular distribution of corticotropin releasing factor receptors.

Authors:  T A Retson; B A Reyes; E J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-08-20       Impact factor: 5.067

5.  FKBP5 moderates alcohol withdrawal severity: human genetic association and functional validation in knockout mice.

Authors:  Ming-Chyi Huang; Melanie L Schwandt; Julia A Chester; Aaron M Kirchhoff; Chung-Feng Kao; Tiebing Liang; Jenica D Tapocik; Vijay A Ramchandani; David T George; Colin A Hodgkinson; David Goldman; Markus Heilig
Journal:  Neuropsychopharmacology       Date:  2014-03-07       Impact factor: 7.853

6.  The sequenced rat brain transcriptome--its use in identifying networks predisposing alcohol consumption.

Authors:  Laura M Saba; Stephen C Flink; Lauren A Vanderlinden; Yedy Israel; Lutske Tampier; Giancarlo Colombo; Kalervo Kiianmaa; Richard L Bell; Morton P Printz; Pamela Flodman; George Koob; Heather N Richardson; Joseph Lombardo; Paula L Hoffman; Boris Tabakoff
Journal:  FEBS J       Date:  2015-07-16       Impact factor: 5.542

Review 7.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

8.  The NSW brain tissue resource centre: Banking for alcohol and major neuropsychiatric disorders research.

Authors:  G T Sutherland; D Sheedy; J Stevens; T McCrossin; C C Smith; M van Roijen; J J Kril
Journal:  Alcohol       Date:  2016-03-14       Impact factor: 2.405

9.  Gene Expression Changes in Glutamate and GABA-A Receptors, Neuropeptides, Ion Channels, and Cholesterol Synthesis in the Periaqueductal Gray Following Binge-Like Alcohol Drinking by Adolescent Alcohol-Preferring (P) Rats.

Authors:  Jeanette N McClintick; William J McBride; Richard L Bell; Zheng-Ming Ding; Yunlong Liu; Xiaoling Xuei; Howard J Edenberg
Journal:  Alcohol Clin Exp Res       Date:  2016-04-08       Impact factor: 3.455

10.  Targeting the Glucocorticoid Receptor Reduces Binge-Like Drinking in High Drinking in the Dark (HDID-1) Mice.

Authors:  Antonia M Savarese; Angela R Ozburn; Pamela Metten; Jason P Schlumbohm; Wyatt R Hack; Kathryn LeMoine; Hazel Hunt; Felix Hausch; Michael Bauder; John C Crabbe
Journal:  Alcohol Clin Exp Res       Date:  2020-03-27       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.